Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Seminars in Hematology|July 24, 2018
Mechanisms of Complement-Mediated Damage in Hematological DisordersRonald P Taylor, Margaret A LindorferAntibodies (Basel, Switzerland)|July 27, 2022
FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying HypothesisMargaret A Lindorfer, Ronald P TaylorCurrent Protocols|October 13, 2023
Measurement of Trogocytosis: Quantitative Analyses Validated with Rigorous ControlsRonald P Taylor, Margaret A LindorferCurrent Opinion in Immunology|July 1, 2008
Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodiesRonald P Taylor, Margaret A LindorferJournal of Immunology Research|November 13, 2025
Inhibition of Complement Will Substantially Reduce the Anemia of MalariaRonald P Taylor, Margaret A LindorferBlood|April 21, 2024
Antibody-drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanismsRonald P Taylor, Margaret A LindorferSeminars in Hematology|March 31, 2010
Antigenic modulation and rituximab resistanceRonald P Taylor, Margaret A LindorferAntibodies (Basel, Switzerland)|September 9, 2020
How Do mAbs Make Use of Complement to Kill Cancer Cells? The Role of Ca2Ronald P Taylor, Margaret A LindorferBlood|December 16, 2014
Fcγ-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developmentsRonald P Taylor, Margaret A LindorferSeminars in Immunology|March 25, 2016
Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodiesRonald P Taylor, Margaret A LindorferPageof 9